Testosterone deficiency, or hypogonadism, is common and may have deleterious effects on men, including decreased overall well-being, reduced sexual function and bone loss.
Despite data demonstrating strong links between testosterone deficiency and significant comorbid conditions (including type 2 diabetes and metabolic syndrome as well as the health benefits of testosterone-replacement therapy [TRT]), some physicians are still hesitant to initiate these therapies. Their reluctance is based on a number of prevailing myths associating TRT with adverse prostate health and recent concerns highlighting the possibility of increased cardiovascular risk.
Written by:
Grober ED. Are you the author?
Division of Urology, University of Toronto; Urologist, Mount Sinai Hospital and Women's College Hospital, Toronto, ON.
Reference: Can Urol Assoc J. 2014 Jul;8(7-8 Suppl 5):S145-7.
doi: 10.5489/cuaj.2309
PubMed Abstract
PMID: 25243038